MeSH tree: D20.215.894
Researchers at the University of Cambridge have developed what they describe as a fundamentally new type of vaccine using artificial intelligence (AI). The vaccine's key component was designed entirely by AI and has now been ...
Jun 9, 2026
0
5
The ongoing Ebola virus outbreak in the Democratic Republic of Congo (DRC) and Uganda has now killed 61 people, with 359 confirmed cases. The Bundibugyo strain of the virus has a fatality rate of between 30% and 50%, and ...
Jun 8, 2026
0
4
A new Penn-led randomized controlled trial has found that AI-powered chatbots can make vaccine-hesitant parents more likely to say they will immunize their children against human papillomavirus (HPV), but no more than standard ...
Jun 8, 2026
0
9
In a remote South African village, Paulina Mhlongo sits in the yard as health workers in green protective gear move briskly through her home, soaking the walls with anti-mosquito insecticide.
Jun 8, 2026
0
6
The first human clinical trial of a universal Sarbeco coronavirus vaccine, developed by the University of Cambridge and spin-out DIOSynVax (DVX) Ltd, has shown that the vaccine is safe and has no significant side effects.
Jun 7, 2026
0
169
A phase 1 clinical trial testing the safety of a leishmaniasis vaccine is set to begin in the coming months—the first vaccine created to protect against the disfiguring skin disease common in tropical regions of the world ...
Jun 6, 2026
0
14
U.S. health secretary Robert F. Kennedy Jr. is pursuing federal government access to most Americans' medical records, in a quest to research a link between vaccines and autism—a connection the medical establishment studied ...
Jun 5, 2026
0
5
When it comes to Ebola outbreaks, it's not often we have two pieces of good news in one week. First, we heard there's new funding of up to US$62 million to fast-track the development of vaccine candidates against the type ...
Jun 5, 2026
0
5
A consistent biological barrier that stops the immune system from making the antibodies most needed to protect the nose and throat from respiratory viruses has been identified. The discovery, led by researchers from the University ...
Jun 4, 2026
0
6
Data from 1,028 people vaccinated with TAK-003 in Catalonia suggests the dengue vaccine has a good tolerability profile in routine clinical practice among travelers from regions where dengue is not endemic. The findings come ...
Jun 3, 2026
0
4
